申请人:Roussel Uclaf
公开号:US04450166A1
公开(公告)日:1984-05-22
Novel N-(4,5-dihydro-thiazol-2-yl)-4-hydroxy-3-quinoline-carboxamides of the formula ##STR1## wherein R is selected from the group consisting of hydrogen and alkyl of 1 to 4 carbon atoms and R.sub.1 is selected from the group consisting of hydrogen, halogen, linear alkyl of 1 to 4 carbon atoms, branched alkyl of 3 to 5 carbon atoms, alkoxy of 1 to 4 carbon atoms, CF.sub.3 --, CF.sub.3 O--, CF.sub.3 S-- and CH.sub.3 S-- in the 6- or 7-position and their non-toxic, pharmaceutically acceptable acid addition salts having a strong anxiolytic activity and a remarkable affinity for benzodiapines receptors and their preparation.
该式中的新型N-(4,5-二氢噻唑-2-基)-4-羟基-3-喹啉羧酰胺,其中R选自氢和1至4个碳原子的烷基,R1选自氢、卤素、1至4个碳原子的直链烷基、3至5个碳原子的支链烷基、1至4个碳原子的烷氧基、CF3-、CF3O-、CF3S-和CH3S-在6-或7-位置,以及它们的非毒性、药用可接受的酸盐,具有强烈的抗焦虑活性和对苯二氮卓类受体的显著亲和力,以及它们的制备。